Associated Papers
Association between the Specific UGT1A1 Promoter Sequence Variant (c-3279T>G) and Unconjugated Neonatal Hyperbilirubinemia.
Tomerak RH et al.
Journal of Tropical Pediatrics, 2016
Ethnic differences in the metabolism, toxicology and efficacy of three anticancer drugs.
Sai K et al.
Expert Opinion on Drug Metabolism & Toxicology, 2011
Functions and transcriptional regulation of adult human hepatic UDP-glucuronosyl-transferases (UGTs): mechanisms responsible for interindividual variation of UGT levels.
Bock KW
Biochemical Pharmacology, 2010
Uridine 5'-diphospho-glucuronosyltransferase genetic polymorphisms and response to cancer chemotherapy.
Ramírez J et al.
Future Oncology (london, England), 2010
UGT1A1 gene polymorphism as a potential factor inducing iron overload in the pathogenesis of type 1 hereditary hemochromatosis.
Romanowski T et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology, 2009
Analysis of inherited genetic variations at the UGT1 locus in the French-Canadian population.
Ménard V et al.
Human Mutation, 2009
UGT1A1 promoter polymorphism increases risk of nilotinib-induced hyperbilirubinemia.
Singer JB et al.
Leukemia, 2007
Intra-ethnic differences in genetic variants of the UGT-glucuronosyltransferase 1A1 gene in Chinese populations.
Zhang A et al.
The Pharmacogenomics Journal, 2007
Combined test for UGT1A1 -3279T-->G and A(TA)nTAA polymorphisms best predicts Gilbert's syndrome in Italian pediatric patients.
Ferraris A et al.
Genetic Testing, 2006
Comprehensive UGT1A1 genotyping in a Japanese population by pyrosequencing.
Saeki M et al.
Clinical Chemistry, 2003
Select a paper to view details